Associate Professor
MD Anderson Cancer Center, The University of Texas
Houston, Texas
Naveen Pemmaraju, MD is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center. After graduating with a degree in Cell and Molecular Biology from Tulane University, he completed medical school at University of Arkansas for Medical Sciences. He went on to complete Internal Medicine training in the Osler Medical Program at Johns Hopkins Hospital. Dr. Pemmaraju completed his Hematology and Oncology fellowship at MD Anderson Cancer Center in 2011, being appointed one of the chief fellows for his program, and stayed on as clinical/research faculty with the Department of Leukemia. His clinical practice and research work has focused on improving outcomes and developing novel therapies for adolescents, young adults, and older adult patients with acute myeloid leukemia (AML), chronic myeloid leukemia (CML), myeloproliferative neoplasms (MPN), and blastic plasmacytoid dendritic cell neoplasm (BPDCN). Under the mentorship of his Department Chair, Dr. Hagop Kantarjian, and Dr. Marina Konopleva, Dr. Pemmaraju established MD Anderson's first active BPDCN clinic, which now serves as a nationwide referral base and an active BPDCN Program. Dr. Pemmaraju has authored or co-authored over 250 manuscripts in the peer-reviewed medical literature. He has presented his work at national/international meetings as posters and oral presentations (including ASH, AACR, ASCO, EHA). Dr. Pemmaraju has been a pioneer in the early stages of developing social media and its interface with hematology/oncology.
Disclosure information not submitted.
Thursday, March 24, 2022
2:45 PM – 3:05 PM
Thursday, March 24, 2022
3:05 PM – 3:20 PM
Thursday, March 24, 2022
2:20 PM – 3:20 PM